Switch to:
More From Other Websites
ETFs with exposure to Neuralstem, Inc. : May 23, 2017 May 23 2017
Neuralstem Reports Last Subject Out in Phase 2 Trial of NSI-189 for Major Depressive Disorder May 17 2017
Neuralstem, Inc. :CUR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017 May 12 2017
Today's Research Reports on Stocks to Watch: MannKind and Neuralstem May 11 2017
Neuralstem reports 1Q loss May 10 2017
Neuralstem Reports First Quarter 2017 Fiscal Results Provides Clinical and Business Update May 10 2017
ETFs with exposure to Neuralstem, Inc. : April 19, 2017 Apr 19 2017
Neuralstem Expands Phase 1 Safety Trial of NSI-566 Neural Stem Cells in Spinal Injury Apr 12 2017
Neuralstem, Inc. :CUR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 29, 2017 Mar 29 2017
Neuralstem Reports Year End 2016 Fiscal Results and Business Update Mar 23 2017
Neuralstem to Present at Oppenheimer 27th Annual Healthcare Conference on March 21 Mar 17 2017
Today's Research Reports on Market Movers: Neuralstem and Real Goods Solar Mar 10 2017
Neuralstem Announces Publication of NSI-566 Data in a Rodent Model of Traumatic Brain Injury Mar 09 2017
Neuralstem to Present at 29th Annual ROTH Conference Mar 08 2017
Neuralstem Announces Publication of NSI-189 Preclinical Data in Journal of Cellular Physiology Feb 28 2017
Neuralstem, Inc. (CUR) Is Up. Here’s Why And What It Means Feb 17 2017
Easier Regulatory Environment Could Send Biotech Industry Skyrocketing in 2017: Today's Reports on... Feb 17 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK